Sunday, October 21, 2007
Suryajyoti Spinning Mills to enter into builders & contractors business
Rohit Ferro starts its production from 3rd furnace
Sunday, October 7, 2007
Do you know The biggest online garage store
Discloser: This is a paid post.
Thursday, September 27, 2007
Sun Pharmaceutical - Caraco Pharmaceuticals Laboratories (Company''s US subsidiary) announces FDA app
Caraco Pharmaceutical Laboratories, Ltd, (Amex: CPD) on September 26, 2007 has announced that the US Food and Drug Administration (FDA) has granted final approval for the Companys Abbreviated New Drug Application (ANDA) for Methimazole Tablets USP, 5 mg and 10 mg (Methimazole).
Methimazole is indicated in the medical treatment of hyperthyroidism. Caracos Methimazole is therapeutically equivalent to the FDA reference listed drug (RLD) listed in the Orange Book, Methimazole Tablets USP, 5 mg and 10 mg, respectively. According to IMS Data, for the twelve months ended June 2007, Methimazole had annual sales of approximately $21 million.
Daniel H. Movens, Caracos Chief Executive Officer, said, We are pleased to receive this approval from the FDA. This marks the third approval in the last 30 days and the sixth approval this quarter. This is in addition to the two tentative approvals granted by the FDA during the period. One of the main drivers of our growth is to continue to expand and strengthen our product portfolio. This will bring our total product selection to 41different products represented by 86 various strengths.
Detroit-based Caraco Pharmaceutical Laboratories Ltd, develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nations largest wholesalers, distributors, drugstore chains and managed care providers.
Market Reports: Market is trading strongly.
The market has gained further momentum. The strong buying is seen in the Metal, It and Realty stocks. The BSE Sensex is trading with a gain of more than 200 points and continued to stay above the physiological 17000 mark. | ||
Rajesh Exports Board to consider Bonus Issue & Stock Split
1. The issue of Bonus Shares.
2. Splitting of existing equity shares of Rs 2 each to equity share of Re 1 each.
Market Commentary: Post Session Market
BSE Metal index surged by 416.96 points to close at 13,502.60 as Sterlite Industries (6.48%), Tata Steel (5.82%), NALCO (4.96%), JSW Steel (2.36%) and SAIL (0.47%) are closed in green.
BSE IT index closed firmly at 4,643.43 as it was up by 141.46 points. Infosys (4.79%), HCL Tech. (3.05%), Satyam (2.56%), Tech Mahindra (2.20%), TCS (1.99%) and Wipro (1.26%) closed in green.
BSE bankex index improved by 111.72 points to close at 9,229.52 as HDFC Bank (4.26%), SBI (2.05%), AXIS Bank (1.61%), ICICI Bank (0.97%) and Andhra Bank (0.74%) closed higher.
BSE oil & gas index grew by 22.16 points to close at 9,639.10 as ONGC (3.74%) and GAIL India (1.15%) closed in green while IOCL (3.09%), RPL (2.77%), HPCL (2.05%) and BPCL (1.27%) closed in red.
BSE Capital goods index closed higher by 36.72 points at 14,691.07 as BEML (2.96%), BHEL (2.60%) and Suzlon energy (0.94%) closed higher while ABB (1.93%), Siemens (0.51%) and L&T (0.21%) closed lower.